- Home
- USCB vs HRTX Comparison
USCB vs HRTX Comparison
Compare USCB & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USCB
- HRTX
- Stock Information
- Founded
- USCB 2002
- HRTX 1983
- Country
- USCB United States
- HRTX United States
- Employees
- USCB N/A
- HRTX N/A
- Industry
- USCB Major Banks
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- USCB Finance
- HRTX Health Care
- Exchange
- USCB Nasdaq
- HRTX Nasdaq
- Market Cap
- USCB 316.4M
- HRTX 276.1M
- IPO Year
- USCB 2021
- HRTX 1987
- Fundamental
- Price
- USCB $17.34
- HRTX $1.35
- Analyst Decision
- USCB Buy
- HRTX Strong Buy
- Analyst Count
- USCB 3
- HRTX 2
- Target Price
- USCB $20.33
- HRTX $4.50
- AVG Volume (30 Days)
- USCB 16.8K
- HRTX 2.6M
- Earning Date
- USCB 07-24-2025
- HRTX 08-08-2025
- Dividend Yield
- USCB 2.30%
- HRTX N/A
- EPS Growth
- USCB 67.08
- HRTX N/A
- EPS
- USCB 1.47
- HRTX N/A
- Revenue
- USCB $88,094,000.00
- HRTX $149,694,000.00
- Revenue This Year
- USCB $26.38
- HRTX $10.62
- Revenue Next Year
- USCB $4.39
- HRTX $12.99
- P/E Ratio
- USCB $11.83
- HRTX N/A
- Revenue Growth
- USCB 32.06
- HRTX 9.78
- 52 Week Low
- USCB $13.85
- HRTX $1.04
- 52 Week High
- USCB $21.86
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- USCB 55.15
- HRTX 36.48
- Support Level
- USCB $17.10
- HRTX $1.33
- Resistance Level
- USCB $17.98
- HRTX $1.43
- Average True Range (ATR)
- USCB 0.52
- HRTX 0.07
- MACD
- USCB 0.06
- HRTX 0.02
- Stochastic Oscillator
- USCB 73.38
- HRTX 45.45
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.